Artemisia Annua Leaf

DRUG3 trials

Sponsors

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, National University of Natural Medicine, Centre de Recherche Médicale de Lambaréné

Conditions

Asymptomatic P.Falciparum MalariaCovid19DiabetesHypertensionObesitySmall Intestinal Bacterial Overgrowth Syndrome (SIBO)

Phase 1

Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial Overgrowth

RecruitingNCT06721884

National University of Natural MedicineSmall Intestinal Bacterial Overgrowth Syndrome (SIBO)

Start: 2025-01-01End: 2026-01-31Target: 32Updated: 2025-06-04

Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum Infection

Not yet recruitingNCT07819825

Centre de Recherche Médicale de LambarénéAsymptomatic P.Falciparum Malaria

Start: 2026-09-01End: 2027-06-01Target: 20Updated: 2026-09-15

Phase 2

Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients

TerminatedNCT04530617

Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranCovid19, Diabetes, Hypertension +1

Start: 2020-10-05End: 2021-06-10Updated: 2021-06-21